The pressure is real. So is the possibility of ease. Let's talk about microdosing, stress, and what helps
Stress shows up differently for each of us.
In the body. In the mind. In how we sleep, speak, move – or freeze.
And yet, we’re often offered the same solutions.
Ones designed for productivity, not presence.
At the*dose, we’re noticing something shift.
More people are turning to microdosing. Not as a fix – but as a quiet way back to themselves.
So we’re opening up a new kind of conversation:
🌀 Free webinar: Stress & Microdosing
Thursday, July 10 at 08:00 PM (CEST)
Join us as we explore what the research says, what lived experience reveals, and how microdosing might support a more sustainable way of being.
🗞 Microdosing in the news
The conversation is growing – and so is the curiosity. Here’s a look at what others are saying:
→ The Times: Magic Mushrooms Enter Mainstream as Treatment for Depression
New Zealand becomes the latest country to allow psychiatrists to prescribe psilocybin, while Czech lawmakers push for clinical legalization. Trials show up to 67% remission in just one week—when paired with proper therapeutic support.
Read article →
→ People Magazine: This Recreational Drug May Help Cancer Patients with Depression
A single 25 mg dose of psilocybin, combined with therapy, brought lasting relief to over half of cancer patients in a recent study – many after just one guided session.
Read article →
→ Neuropsychopharmacology: Rapid Antidepressant Effects from Vaporized DMT
A new clinical trial found that a single dose of vaporized DMT brought fast and sustained remission to up to 50% of participants with treatment-resistant depression.
Read article →
Why these stories matter for the*dose community
- These aren’t just underground stories – they reflect active clinical momentum. From legislative shifts in NZ and Czechia to pioneering DMT trials, psychedelics are moving fast.
- Psilocybin and DMT are showing therapeutic promise not just for stress, but also for depression’s toughest cases – including terminal illness and treatment-resistant conditions.
- These developments underscore one of our webinar’s core questions: What role might microdosing or therapy grade dosing play in holistic stress support?
The world is loud. Your way forward doesn’t have to be.
See you on July 10.
Take good care,
the*dose team
